BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10762305)

  • 1. Simultaneous occurrence of the 5q- syndrome and multiple myeloma.
    Rios R; Sole F; Gascon F
    Clin Lab Haematol; 2000 Feb; 22(1):49-53. PubMed ID: 10762305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Association between multiple myeloma and acute myeloid leukemia secondary to myelodysplastic syndrome].
    Jennane S; Eddou H; Mahtat el M; Konopacki J; Souleau B; Malfuson JV; Foissaud V; de Revel T
    Ann Biol Clin (Paris); 2013; 71(5):581-4. PubMed ID: 24113443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelodysplastic syndrome with isochromosome 5p and trisomy 8 after treatment of a multiple myeloma.
    Jimenez-Sousa MA; Ferro MT; Talavera M; Villalon C; Cabello P; Laraña J; Herrera P; Garcia Sagredo JM
    Cancer Genet Cytogenet; 2010 Dec; 203(2):345-7. PubMed ID: 21156257
    [No Abstract]   [Full Text] [Related]  

  • 4. Gaucher disease and myelodysplastic syndrome with isolated del(5q).
    Villarrubia J; Rodríguez-Gambarte JD; Abalo L; Vallés A; Alonso-Domínguez JM; Velasco-Rodríguez D
    Br J Haematol; 2014 Apr; 165(2):164. PubMed ID: 24611589
    [No Abstract]   [Full Text] [Related]  

  • 5. A paediatric myelodysplastic syndrome with 5q deletion associated with Fanconi anaemia.
    Kornreich L; Soulier J; Grange B; Girard S; Ouchée-Chardin M; Ceraulo A
    Pediatr Blood Cancer; 2020 Jul; 67(7):e28369. PubMed ID: 32379395
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapy-related myelodysplastic syndrome. Two cytogenetically unrelated abnormal clones in a patient with multiple myeloma.
    Abeliovich D; Yehuda O; Ben-Neriah S; Matzner Y
    Cancer Genet Cytogenet; 1993 Oct; 70(2):117-9. PubMed ID: 8242590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myelodysplasia during the course of myeloma. Restriction of 17p deletion and p53 overexpression to myeloid cells.
    Soenen V; Preudhomme C; Roumier C; Laï JL; Lepelley P; Facon T; Pagniez D; Fenaux P
    Leukemia; 1998 Feb; 12(2):238-41. PubMed ID: 9519788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5q- syndrome in a child with slowly progressive pancytopenia: a case report and review of the literature.
    Pitman SD; Victorio A; Rowsell E; Morris J; Wang J
    J Pediatr Hematol Oncol; 2006 Mar; 28(3):115-9. PubMed ID: 16679931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant MDS with isolated 5q deletion and MGUS: case report and review of molecular aspects.
    Nolte F; Mossner M; Jann JC; Nowak D; Boch T; Müller NZ; Hofmann WK; Metzgeroth G
    Eur J Haematol; 2017 Mar; 98(3):302-310. PubMed ID: 27862375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5q- syndrome and multiple myeloma diagnosed simultaneously and successful treated with lenalidomide.
    Ortega M; Mallo M; Solé F; Sánchez-Morata C; López-Andreoni L; Martínez-Morgado N; Gironella M; Valcárcel D; Vallespí T
    Leuk Res; 2013 Oct; 37(10):1248-50. PubMed ID: 23891188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-.
    Mallo M; Arenillas L; Espinet B; Salido M; Hernández JM; Lumbreras E; del Rey M; Arranz E; Ramiro S; Font P; González O; Renedo M; Cervera J; Such E; Sanz GF; Luño E; Sanzo C; González M; Calasanz MJ; Mayans J; García-Ballesteros C; Amigo V; Collado R; Oliver I; Carbonell F; Bureo E; Insunza A; Yañez L; Muruzabal MJ; Gómez-Beltrán E; Andreu R; León P; Gómez V; Sanz A; Casasola N; Moreno E; Alegre A; Martín ML; Pedro C; Serrano S; Florensa L; Solé F
    Haematologica; 2008 Jul; 93(7):1001-8. PubMed ID: 18591625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of psu dic(6;5)(p21.3;q13) with reverse chromosome painting in a patient with secondary myelodysplastic syndrome following treatment for multiple myeloma.
    Lee-Jones L; Ramsahoye B; Booth M; Thompson P; Whittaker J; Hoy T
    Cancer Genet Cytogenet; 2004 Jan; 148(1):49-54. PubMed ID: 14697641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Myelodysplastic syndrome associated with 5q deletion, review of 3 cases].
    Khanfir A; Frikha M; Mseddi S; Elloumi M; Daoud J; Makni F; Amouri A; Gargouri J; Saad A; Souissi T
    Tunis Med; 1997 Mar; 75(3):127-31. PubMed ID: 9506035
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytogenetic features of 5q deletion and 5q- syndrome in myelodysplastic syndrome in Korea; marker chromosomes proved to be chromosome 5 with interstitial deletion by fluorescence in situ hybridization.
    Lee HR; Oh B; Hong DS; Zang DY; Yoon HJ; Kim HJ; Kim I; Ahn JS; Cheong JW; Lee KA; Cho KS; Lee MH; Bang SM; Kim TY; Yun YM; Min YH; Lee YK; Lee DS;
    Cancer Genet Cytogenet; 2010 Dec; 203(2):193-202. PubMed ID: 21156233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haematological and cytogenetic responses after only 7 days of Lenalidomide in a patient with myelodysplastic syndrome and chromosome 5q deletion.
    Hadiji Mseddi S; Kallel F; Kassar O; Elloumi M; Jedidi I; Sennana H; Fenaux P
    Leuk Res; 2011 Sep; 35(9):e175-6. PubMed ID: 21658768
    [No Abstract]   [Full Text] [Related]  

  • 16. The 2016 revised World Health Organization definition of 'myelodysplastic syndrome with isolated del(5q)'; prognostic implications of single versus double cytogenetic abnormalities.
    Gurney M; Patnaik MM; Hanson CA; Litzow MR; Al-Kali A; Ketterling RP; Tefferi A; Gangat N
    Br J Haematol; 2017 Jul; 178(1):57-60. PubMed ID: 28419466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryptic 5q deletion in a patient with myelodysplastic syndrome.
    Medlock R; Barrans S; Cargo C; Kelly R
    Br J Haematol; 2017 May; 177(3):347. PubMed ID: 28294297
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of 5q- myelodysplasia in a patient with sarcoidosis.
    Tunkel AR; Sebastianelli KJ; Pandit N; Brody JI
    Am J Hematol; 1990 Jul; 34(3):225-7. PubMed ID: 2363416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5q- syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10).
    Ureshino H; Kizuka H; Kusaba K; Sano H; Nishioka A; Shindo T; Kubota Y; Ando T; Kojima K; Kimura S
    Int J Hematol; 2017 May; 105(5):692-696. PubMed ID: 27914067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelodysplastic syndromes with del(5q): indications and strategies for cytogenetic testing.
    Haferlach C; Bacher U; Tiu R; Maciejewski JP; List A
    Cancer Genet Cytogenet; 2008 Dec; 187(2):101-11. PubMed ID: 19027491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.